RU31712U1 - Height-adjustable table stand - Google Patents

Description

Teterina device for correction

functional systems of the body

The utility model relates to medicine, and more specifically to a device for correcting the functional systems of the human body, in particular, to improve visual functions.

The utility model can be used to correct the visual, central nervous, immune, endocrine, cardiovascular and other body systems. In particular, the invention can be used for the treatment and prevention of various pathologies of the organ of vision, including glaucoma, cataracts, pathology of the retina and optic nerve, for vision correction in congenital weak vision, inability to correct with glasses, myopia, hyperopia, presbyopia, strabismus.

A device for correcting the functional systems of the human body (patent No. 2098059, class A 61 F 9/00, 1997), containing glasses with two light-insulated eyepieces, each of which has a light-scattering reflector, inside which a source of LED radiation is rigidly known, is known. At the same time, the device has a master oscillator, a power supply, a regulator of brightness and pulse frequency of light emission.

However, a light-scattering reflector in light-insulated eyepieces does not provide a response of visual neurons that are important for their activation when illuminating the entire retina with diffuse (scattered) light, which causes mutual suppression7 A61F9 / 00

of man

the increase in the excitatory and inhibitory zones of the receptive fields of visual neurons is a phenomenon of antagonism. In this regard, this device does not give the desired effect, and the treatment time is extended, especially with color therapy of advanced stages of the disease.

The technical result of the utility model is to increase efficiency, reduce treatment time.

The technical result is achieved by that. that the device for correcting the functional systems of the human body contains glasses with two light-insulated eyepieces, each of which has a light-diffusing reflector, with a light radiation source rigidly fixed inside it, opposite which there is a light-tight screen with 5-8 holes with a diameter of 1.5h-3.5 mm . The device also contains a master oscillator, a controller for blinking light frequency and a power supply unit, a brightness controller for light radiation, a control unit, a modulating pulse generator and a modulator connected in series, the inputs of which are connected respectively to the outputs of the controller for blinking light frequencies, and the outputs to corresponding controller inputs brightness of light radiation, two switches, each of which has its inputs connected to a regulator of brightness of light radiation, and the output to a source ku light radiation, which is a set of LED emitters of different wavelengths of the light emission control unit, outputs of which are connected to the control inputs of the frequency controller blinking light emission, light emission luminance controller and switch.

In FIG. 1 schematically shows a device for correcting the functional systems of the human body, made according to the invention, a top view; in FIG. 2 is an electronic diagram of a device made according to the invention; in FIG. 3 is a panel of a control point of a device made according to the invention; in FIG. 4 - lightproof screen.

A device for correcting the functional systems of the human body contains glasses (Fig. 1) with two light-insulated eyepieces. Each eyepiece has a light-scattering reflector 1, inside which a light-tight screen 2 is installed, LED emitters 3, 4 of different wavelengths are fixed against it: from 400 to 700 nm. In FIG. 4 shows a 5-hole lightproof screen. Holes can be up to 8, while their diameter is from 1.5 to 3.5 mm. The device includes a master oscillator 5 (Fig. 2), a regulator 6 of the blinking frequency of the light radiation, forming two antiphase pulse sequences in the frequency range from 0.06 to 1 Hz, a regulator 7 of the brightness of the light radiation, two switches 8, 9, each which provides a given light effect on the corresponding eye, and in series connected control unit 10, the shaper 11 of the modulating pulses with a frequency of 2 to 64 Hz and the modulator 12.

The master oscillator 5 is connected to the input 13 of the controller 6 of the blinking frequency of the light radiation having two outputs connected to the corresponding inputs 14, 15 of the modulator 12, the two outputs of which are connected to the corresponding inputs 16, 17 of the controller 7 of the brightness of the light radiation, connected by its outputs to the input 18 , 19 of the corresponding switch 8, 9. The control unit 10 with its outputs is connected to the input 20 of the controller 6 of the blinking frequency of light radiation, input 21 of the controller 7 of the brightness of light radiation, inputs 22, 23 of each switch 8, 9 and ode 24 of the shaper 11 of the modulating pulses, the output of which is connected to the input 25 of the modulator 12. The output of each switch 9 is connected to the LED emitters 3, 4 of the corresponding eyepiece.

In this case, the device has a remote control 26 (Fig. 3) control and monitoring connected to its input to the power supply. Moreover, in the case of using industrial frequency voltage, a power supply unit is used, which is an adapter 27, which converts this voltage to a voltage of 9-12 V, safe for the user. The control and control panel 26 has a transparent window 28 with indicator LEDs installed therein corresponding to LED emitters of 8, 9 colors, which allow controlling the wavelength of light radiation, pseudo-sensor switches 6, 8, 9, 11 12 for setting various modes of light emission and adjustment its brightness, a timer 29, which ensures that the entire device is turned off after a predetermined time, and a connector 30, to which glasses 1 are connected.

The device operates as follows.

The patient wears glasses, in the eyepieces of which inside the light-scattering reflectors 1 there is a set of LED emitters 3 of different wavelengths from 400 to 700 nm. When voltage is applied to the input of the device, the light-emitting frequency control knob 6 generates two out-of-phase pulse sequences in the frequency range from 0.06 to 1 Hz and goes to the inputs 14, 15 of the modulator 12, the pulse train generator 11 generates a pulse sequence (meander) with a frequency from 2 to 64 Hz, which modulates in the modulator 12 the amplitude of the signals of the controller 6 of the blinking frequency of the light radiation. The modulated signals are regulated in amplitude in the dimmer 7 and are fed through switches 8, 9 to the LED emitters 3, 4 of the corresponding wavelength.

located in O1sulyar. Using the switches 8 and 9 set the desired color for each of the eyes. Using the controller 6 of the blinking frequency of the light radiation, the blinking frequency of the light radiation is set in the range from 0.06 to 1 Hz. Adjustment of the level of output radiation is carried out by means of the regulator 7 of the brightness of the light radiation stepwise through 1.5 dB (4 positions). The maximum brightness of the radiation is from 1.5 mW (for red) to 0.05 mW (for other colors). By means of a shaper 11 modulating pulses include pulse modulation of rhythms with a frequency of 8.16 or 32 Hz. Set the operation mode of the device depending on the pathology. The electronic circuit allows the formation of the following radiation modes:

- alternating effects on the eyes with a period of 4-8 s;

-periodic exposure to one of the eyes and continuous exposure to the other;

- Any of the above modes with modulation of the radiation meander with a frequency of 8, 16 or 32 Hz.

In this case, you can affect both eyes with the same or different wavelengths:

-660 nm (red color);

-600 nm (orange color);

-567 nm (green color);

-470 nm (blue color).

Timer 29 ensures that the device turns off after a certain time (for example, 8.5 minutes).

During the operation of the above scheme, pulsed light emission from LEDs 3, 4 occurs in the light-scattering reflector.

Light passes through the openings of the opaque screen, as a result of which the patient observes the pulsation of the light stimuli.

The presence of radiation brightness control allows you to quickly set the brightness of the LED emitters individually for each of the patients.

To set various modes of light emission and adjust its brightness, pseudosensory push-button switches b, 7 ,, P, 12 are used. The radiation wavelength is controlled by indicator LEDs located in the transparent window 28 of the control and control panel 26 of the device.

The presence of a screen with small openings provides a response of the visual neurons of the retina of the eye and brain due to stimulation or the exciting or inhibitory zone of the receptive fields of the visual neurons, i.e. the mechanism of the phenomenon of antagonism. As a result, the visual function and the function of regulatory structures of the brain (hypothalamus, pituitary, etc.) increase, which increases the effectiveness of treatment and shortens the treatment time.

The device has small dimensions, which allows it to be used both in specialized clinics and at home. The power consumption is not more than 40 mW, and the mass (without glasses and a network adapter) does not exceed 200 g.

The device is illustrated by the following examples.

Example 1.

Natsient I., 47 years old. Diagnosis: presbyopia. Complaints of decreased vision during visual work near. Before treatment: visual acuity of the right eye of 0.9; left eye 1.0. But for the near table, it reads a font without reaction with the right eye No. 7 (visual acuity 0.4), with the left eye - No. 5 (visual acuity, 0.6). After one session of color therapy using the proposed device according to the table for near reads without correction with the right eye font No. 5 with the left eye No. 2 (visual acuity 0.6 and 0.9, respectively). Therefore, this patient does not need glasses for close-range visual work. Example 2. Patient T., 46 years old. Complaints of decreased vision during visual work near. Diagnosis: presbyopia. Visual acuity of the right eye of 0.9, the left eye of 1.0. According to the table for near, he reads the font. No. 6 without the right eye, and No. 1 with the left eye. After color therapy carried out for 5 days using the proposed device, the font for the near reads font No. 2 without correction (visual acuity 0.9). Example. 3. Patient K., 56 years old. Complaints of decreased vision both in the distance and near. Diagnosis: presbyopia, hyperopia of a weak degree in both eyes. Before treatment: visual acuity of the right eye of 0.2, spheres. + 1, OD 1.0; left eye 0.1, spheres. + 1.5D 1.0. According to the table for near without correction, he distinguishes between the font JVfo 10 with the right and left eye (visual acuity 0.1). With correction of spheres / + 2.5D, corresponding to the age of the patient, he reads font No. 8 (visual acuity 0.3). After 3 sessions of color therapy using the proposed device, visual acuity into the distance without correction of the right eye 0.7, left eye 0.5, binocular 0.8. After the 5th session, 1.0 and 0.6, respectively. According to the table for near without correction the right and left eye reads the font

No. 4, which corresponds to visual acuity near 0.7. Consequently, after treatment, the patient does not need corrective glasses for both distance vision and close visual work.

All patients with presbyopia (45 people) in the process of color retinal stimulation through an opaque screen placed on a light-scattering reflector in glasses observed pulsation of light stimuli corresponding to the screen openings, which indicated a response of the visual neurons of the retina of the eye and brain to color stimuli.

Thus, the present invention provides increased functions of the visual neurons of the retina and brain, which significantly reduces the treatment time and is an effective method for correcting presbyopia without optical lenses, as well as preventing its progression.

The effect of retinal color stimulation using the proposed device on visual functions in case of myopia, hyperopia of refractive amblyopia, initial cataract, glaucoma, retinal and optic nerve pathology and the general condition of patients with concomitant diseases (hypertension, neurasthenic syndrome, central nervous system dysfunction, endocrine, and other digestive organs, was studied). systems).

Example 4

Patient M., 34 years old .. Diagnosis: refractive amblyopia, complex myopic astigmatism in both eyes. Before treatment: visual acuity of the right and left eye of 0.06, with a correction of 0.5. After a course of treatment for 8 days using the proposed device, the visual acuity of the right and left eye is 0.3 with a correction of 0.8. Therefore, despite the patient's age (34 years), high visual acuity was achieved with refractive amblyopia of both eyes.

Example 5

Patient R., 13 years old. Diagnosis: progressive myopia of moderate degree. Before treatment, the visual acuity of the right and left eyes is 0.06, with correction of the spheres. -4, OD 1.0. After a course of treatment for 10 days, respectively, 0.08, with correction of the spheres. -2.5 D 1.0. A decrease in optical correction by 1.5 D in this patient indicates that the proposed device provides prevention of the progression of myopia and a decrease in the strength of corrective glasses.

Example 6

Patient 3., 47 years old. Diagnosis: mild myopia. Prior to treatment, visual acuity of the right and left eye is 0.1, with correction of the spheres. 2.5 D 1.0; after the course of treatment using the proposed device, the visual acuity of the right eye of 0.8, the left eye of 0.5, with correction of the spheres. -1.0 D 1.0. this patient achieved a significant increase in visual acuity without correction and, therefore, the need for constant wearing of corrective glasses disappeared.

Example 7

Patient D., 67 years old. Diagnosis: initial cataract of the right eye, artifact and subluxation of the intraocular lens of the left eye.

Before treatment: visual acuity of the right eye 0.1, spheres. + 3.0 D 0.5; left eye 0.01, spheres. + 11, OD 0.2.

After retinal color stimulation using the proposed device, the visual acuity of the right eye of 0.2 spheres. + 3, OD 1.0; left eye with correction of spheres. + 10, OD 0.3.

9MShTs

Thus, the normalization of visual acuity in the right eye indicates that the present invention provides for the prevention of cataract progression in the initial stage and the normalization of visual acuity. In addition, it prevents the psycho-emotional stressful experiences that took place before color therapy in this patient in connection with the upcoming operation on the best eye and undergoing an unsuccessful operation on the left eye.

Example 8

Patient M., 6 years old. Diagnosis: congenital atrophy of the optic nerve, medium-sightedness of moderate degree in both eyes, convergent strabismus, very high degree dysbinocular amblyopia and left eye nystagmus. From birth, the child is under the supervision and treatment of a neurologist and optometrist.

Before treatment: visual acuity of the right eye of 0.2 spheres. + 3, OD - 0.4; left eye 0.01, visual fixation is absent. The angle of deviation of the left eye to the nose is from 30 to 50 °.

After color stimulation using the proposed device for 15 days, the visual acuity of the right eye is 1.0 without correction; of the left eye with a correction of 0.08 with an eccentric unstable fixation, nystagmus is negligible, the strabismus angle decreased to 10-20 °.

Thus, the child achieved normalization of visual acuity of the right eye, improved vision of the left eye and a significant decrease in the angle of squint.

Example 9

Patient L. .. 12 years old. Diagnosis: congenital partial atrophy of the optic nerve of the right eye, complete atrophy of the optic nerve and convergent strabismus of the left eye, congenital cerebral palsy, right-sided, Q

myparesis. The girl is constantly being treated by an optometrist and a neurologist.

Before treatment: visual acuity of the right eye of 0.3, spheres. + 1, OD 0.5; left eye - O (zero). Angle of deviation to the nose 10 °.

After treatment using the proposed device, the visual acuity of the right eye is -0.5, spheres. -1, OD 1.0; left eye 0. Strabismus angle 0 °

Thus, the proposed device provides high efficiency in congenital gross pathology of the optic nerve, as evidenced by the normalization of visual acuity in the best eye, the disappearance or significant reduction of strabismus.

Example 10

Patient D., 67 years old. Diagnosis: initial cataract of both eyes. Concomitant diseases: IHD, angina pectoris, VVD, cephalgia, gastrointestinal dysfunction, widespread osteochondrosis of the spine.

Before treatment: visual acuity of the right and left eye 0.7, the glasses are not corrected. After color stimulation using the proposed device for 7 days, the visual acuity of the right and left eyes returned to normal and amounted to 1.0. Along with the improvement of visual functions, the patient's general condition also improved: headaches and pains in the spine disappeared, gastrointestinal function improved, and working capacity improved.

Example 11

Patient A., 24 years old. Diagnosis: high degree hyperopia of both eyes. Before treatment, visual acuity of the right eye of 0.7, the left eye of 0.3. spheres. + 1.5D 0.9 and 0.7, respectively. Refraction of both eyes hyperopia in 6, OD. After color stimulation using the proposed device 11MMM

Royal eye visual acuity without correction of the right eye 1.0; left eye 0.8. The refraction of both eyes decreased and was equal to ginermetropia in 4, OD.

Thus, the normalization of visual acuity and a decrease in the degree of hyperopia were achieved in this patient.

Example 12

Patient Sh., 64 years old. Diagnosis: diabetic retinopathy, state after laser coagulation of the retina of both eyes, initial cataract, diabetes mellitus. Prior to treatment: visual acuity of the right eye 0.1, left eye 0.4, with correction of the spheres. + 1, OD 0.2 and 0.6, respectively. Blood sugar 7.3-7.8 mmol / l during treatment with antidiabetic drugs. After color stimulation using the proposed device, the visual acuity of the right eye of 0.3, is not corrected, the left eye of 0.7, spheres. + 1, OD 1.0. Blood sugar content is 5.4-5.8 mmol / L. The general condition of the patient has improved significantly.

Thus, a significant positive effect was achieved with difficult to treat complications of diabetes mellitus - diabetic retinopathy. At the same time, the blood sugar level returned to normal.

Example 13

Patient L., 64 years old. Diagnosis: macular degeneration of both eyes: wet form on the right and form on the left eye, initial cataract of both eyes. A year ago, laser coagulation was performed and medication is periodically performed.

Before treatment: visual acuity of the right eye 0.1; left eye 0.1; with correction of spheres. + 2.5D - 0.3 and 0.5. After color stimulation using the proposed device, the visual acuity of the right eye of 0.5; left eye.

Thus, the achieved high visual acuity with almost never accepted conventional drug and laser treatment of such a retinal pathology as macular degeneration indicates that the proposed device is highly effective both in improving visual functions and in the prevention of blindness in this disease.

Claims (1)

Height-adjustable table support containing a lower element made of a metal pipe, having two holes, and an upper element that enters the lower element with the possibility of telescopic movement in it, a fixing element and two screws interacting with the fixing element by means of screw cuts through holes in the lower element, characterized in that the upper element has a slot facing the holes in the nickel element, and the locking element is installed inside the upper element.